Combination of drugs could prevent thousands of heart attacks
Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all.…
Category: Publications
Obesity in patients with familial hypercholesterolaemia globally
The EAS FHSC Investigators at the FHSC Coordinating Centre at Imperial College London present their article titled: Overweight, obesity, and cardiovascular disease in heterozygous familial…
Debunking the myth: familial hypercholesterolaemia does not protect against diabetes
The FHSC Investigators, led by the FHSC Coordinating Centre at Imperial College London, present an article titled Association of BMI, lipid-lowering medication, and age with…
Women, lipids and atherosclerotic cardiovascular disease: A call to action from the European Atherosclerosis Society
Gothenburg, August 23, 2023 Cardiovascular health of women is often neglected, with risk underappreciated, diagnosis delayed and treatment less than optimal. This new statement from…
NEW! Helping practitioners to translate the guidelines into patient care – The Clinician’s Handbook, Update 2023 is available now
After The 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias were released, EAS published The Clinician’s Handbook: Dyslipidaemia and Atherosclerosis Prevention, Diagnosis and Treatment as…
Updated EAS statement on homozygous familial hypercholesterolaemia: driving better care of patients globally
Gothenburg, May 3, 2023 Homozygous familial hypercholesterolaemia (HoFH), the most severe form of this high cholesterol disorder, affecting about one in 300,000 people, is poorly…
EAS Publication
EAS Atherosclerosis Journal: call for original papers on “The link between diabetes and cardiovascular disease”
